封面
市場調查報告書
商品編碼
2041948

核子醫學市場展望(2026 年)

2026 Nuclear Medicine Market Outlook Report

出版日期: | 出版商: IMV Medical Information | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

IMV發布的「核子醫學市場展望(2026)」分析了核子醫學檢查的數量、採購計畫以及未來核子醫學設備採購的選擇標準。該報告深入探討了核子醫學管理人員如何看待其部門的未來前景,以及他們如何根據行業挑戰確定優先事項。報告詳細分析了核子醫學市場趨勢,包括核子醫學檢查的數量、已部署設備的性能、原始設備製造商 (OEM) 和第三方服務供應商的使用情況、設備採購計劃、放射性藥物的使用和預算、治療診斷學以及設施運營特點。所有分析結果均基於已確定的核子醫學機構。

本報告所獲取的信息

核子醫學科的優先事項與未來展望

  • 核子醫學科的主要工作重點是什麼?
  • 哪些因素將對新墨西哥州的未來前景產生最大影響?
  • 未來採購核醫相關產品時,優先考慮哪些資訊來源?
  • 在核子醫學領域,人工智慧應用的首要優先順序是什麼?

核子醫學檢查

  • 2026 年 NM(自然採礦)程序的數量發生了怎樣的變化?
  • 各類核子醫學檢測的組成趨勢是什麼?

擬引進的核子醫學掃描儀數量及採購計劃

  • 每種類型的設施中安裝了多少台固定式核磁共振設備?
  • 以部署單元數量計算,各供應商的市佔率趨勢如何?
  • 主要NM功能的採用率是多少?
  • NM設備的預期使用壽命是多久?多久之後更換?
  • 全新NM掃描器與翻新NM掃描器的構成比是多少?
  • NM Site 使用哪些類型的服務供應商?
  • NM用戶目前的品牌忠誠度狀況如何?
  • 未來核子醫學掃描儀的主要採購標準是什麼?
  • 2026年至2028年NM掃描器的銷售預測是多少?

治療診斷學

  • 最常見的治療診斷學程序有哪些?
  • 哪一種放射性藥物應用最廣泛?

設施運作特點

  • 神經醫學科共聘用了多少名技術人員、護士、行政人員、影像檢查助理和秘書?
  • 貴公司有多少百分比的設施和檢測項目使用了外部影像判讀服務?

市場調查方法

本報告利用了 IMV 在 2026 年 2 月和 4 月進行的線上調查結果。該調查涉及從美國各地醫院和影像中心隨機抽取的 300 名核醫部門經理、主管和首席技術人員。

目錄

  • 從洞察到影響:如何將這份報告轉化為策略優勢
  • 關於核子醫學科2026年下一年度任務的優先事項調查
  • 醫院和非醫院:關於核子醫學科室2026年未來一年任務優先事項的調查
  • 根據截至 2026 年的調查,按設施類型分類的核子醫學科未來一年的任務重點
  • 根據 IMV 調查年份,核子醫學科在 2011 年至 2026 年期間的優先事項。
  • 一份關於影響貴機構核醫未來發展前景(截至 2026 年)的因素的調查。
  • 醫院和非醫院:一項關於影響貴機構未來幾年(截至2026年)核醫發展前景的因素的調查
  • 影響貴機構未來幾年核醫發展前景的因素(依機構類型分類,截至 2026 年的調查)
  • 影響貴機構未來幾年核醫發展前景的因素(依IMV調查年份,2011-2026年分類)
  • 新墨西哥州各部門人工智慧和機器學習工具使用優先順序排名(截至2026年)
  • 新墨西哥州各部門人工智慧和機器學習工具使用優先排名(按站點類型,第一/第二名)(截至 2026 年)
  • 新墨西哥州各部門人工智慧和機器學習工具的當前使用和考慮調查(截至2026年)
  • 針對核子醫學科室人工智慧和機器學習工具的當前使用情況和考慮情況的調查,按醫院和非醫院環境分類(截至 2026 年)
  • 截至2026年,各類型核子醫學科室人工智慧與機器學習工具的使用現狀
  • NM手術流程、報銷、收入和淨利潤展望(與2025年相比)
  • IMV調查:新墨西哥州年度手術量和收入預測(2011-2026)
  • 未來幾年正在考慮的策略行動(截至2026年的調查)
  • 未來幾年正在考慮的策略行動(按醫院和非醫院部門分類,調查截至 2026 年)
  • 未來幾年正在考慮的策略行動(按場地類型分類)(截至 2026 年的調查)
  • 人工智慧對2025年新墨西哥州政府的影響—開放式回答摘要
  • 2026年人工智慧對新墨西哥州政府影響的預測—開放式回答摘要
  • 關於新墨西哥州設備和服務的開放式回答提案
  • 涉及核醫病患的研究總數(醫院和非醫院機構,2002-2025 年)
  • 核子醫學設施與病患研究分佈(依設施類型分類,2026 年)
  • 依醫療機構類型分類的每家醫療機構平均核醫病患檢查次數趨勢(2017-2025 年)
  • 2025 年核醫病患檢查中,使用 SPECT-CT、僅 SPECT 和僅平面相機進行的檢查分佈(按機構類型分類)
  • 一項關於截至 2026 年未來三年內(或計劃未來三年)可用的或計劃使用的核醫學臨床應用類型的調查。
  • 根據截至 2026 年的調查,按設施類型分類,目前提供或計劃在未來三年內提供的核醫臨床應用類型。
  • 2025 年核子醫學研究中的病患組成(依治療類別,所有機構)
  • 核子醫學病患篩檢現況(依篩檢方法分類,2018-2025 年)
  • 核子醫學病患篩檢分佈(依篩檢類型、醫院和非醫院分類,2010-2025 年)
  • 根據機構類型分類,預計 2026 年 NM 患者研究總數將比 2025 年增加、保持不變或減少。
  • 與 2025 年相比,2026 年 NM 患者的比例會增加、維持不變或減少(以手術類型分類)?
  • 根據 2026 年進行的一項調查,本文件概述了進行核醫學檢查的機構百分比以及每個機構每年平均進行的核醫學患者檢查數量(按檢查類型和醫院/非醫院環境分類)。
  • 按IMV研究年份和手術類型分類的進行核子醫學檢查的機構百分比(2018-2025年)
  • 2025 年住院病患、門診病人及急診病患核醫研究現況(依醫療機構類型分類)
  • 截至 2026 年,使用診斷性電腦斷層掃描進行病患檢查的 SPECT/CT 檢查機構百分比(調查結果)
  • 僅進行診斷性電腦斷層掃描而不合併使用 SPECT 掃描的 SPECT/CT 機構百分比(截至 2026 年的調查)
  • 核子醫學設施和攝影機的分佈(醫院設施和非醫院設施)(截至2026年的調查)
  • IMV 調查數據按年份顯示,2011-2026 年醫院和非醫院設施中安裝的核醫攝影機的數量趨勢。
  • 根據 2026 年調查,核醫攝影機安裝數量和設施類型分佈。
  • 核子醫學攝影機安裝市場佔有率(按製造商分類,截至 2026 年)
  • 依安裝年份分類的核醫攝影機安裝數量分佈(截至2026年的調查)
  • 依安裝年份及安裝位置類型分類的核醫攝影機安裝數量分佈(截至2026年的調查)
  • 核醫攝影機安裝數量分佈(依攝影機類型和安裝位置類型分類)(截至2026年的調查)
  • 核醫攝影機安裝基礎配置趨勢(依攝影機類型、IMV調查年份分類,2011-2026年)
  • 按相機類型分類的核子醫學相機市場佔有率(截至2026年)
  • 核醫攝影機安裝市場佔有率(截至 2026 年過去 6 年的安裝量)
  • 以CT切片數量分類的已安裝SPECT/CT相機分佈(截至2026年的調查)
  • 根據醫療機構類型,使用通用心臟攝影機還是專用心臟攝影機進行 SPECT 或 SPECT/CT 檢查的情況(截至 2026 年的調查)
  • 根據設施類型,SPECT 或 SPECT/CT 是否配備固體檢測器(截至 2026 年的調查)
  • 按醫療機構類型分類的 SPECT 或 SPECT/CT 設備是全新購買還是翻新購買(截至 2026 年的調查)
  • 核醫攝影機主要服務支援的電力分配(按設施類型分類)(截至 2026 年的調查)
  • 核醫攝影機主電源供應分佈(依安裝年份,截至 2026 年)
  • 核子醫學攝影服務合約類型(按設施類型分類)(截至 2026 年的調查)
  • SPECT 或 SPECT/CT 是全新購買還是翻新購買,以及 NM 服務支援的主要來源(截至 2026 年)。
  • 未來三年核醫相機採購計畫調查(截至2026年)
  • 計劃在未來三年內購買核醫攝影機的機構百分比,以IMV調查年份(2011-2026年)細分
  • 關於計劃於2026年採購的核子醫學攝影機類型的調查
  • 2011 年至 2026 年計畫購買的核醫攝影機類型,按 IMV 調查年份細分。
  • 一項關於計劃中的核醫相機是通用相機還是心臟專用相機的調查(截至 2026 年的調查)。
  • 計畫使用的SPECT/CT相機(按CT切片數)
  • 依設施類型針對新建和維修的核醫攝影機的引進計畫進行調查。
  • 關於核子醫學攝影機更換和新增計劃的調查(截至2026年的調查)
  • 將製造商列為下一台核醫相機潛在供應商的網站百分比(2026 年進行的調查)
  • 品牌忠誠度:核子醫學相機製造商根據截至 2026 年的相機安裝數量進行考慮(截至 2026 年)。
  • 2026年至2028年計畫購買的所有相機的年度預算狀況(2026年進行的調查)
  • 2026財政年度核醫設備預算分配狀況(截至2026年的調查)
  • 2025-2028財政年度新墨西哥州設備預算分配(2026年進行的調查)
  • 2025-2028財政年度按站點類型分類的新墨西哥州設備預算分配(2026年進行調查)
  • 依機構類型及IMV調查年份(2018-2026年)分類的各機構平均核醫設備預算
  • 根據 2026 年調查(2026 年調查),預計在 2026 年至 2028 年期間完成資本項目的地點百分比。
  • 基於2026年調查回覆的核醫攝影機更換週期
  • 截至 2026 年調查,提供放射性核種治療的機構(依機構類型分類)
  • 放射性核種治療:核醫治療機構分佈及所進行的治療計畫(依機構類型分類,2025 年)
  • 使用放射性核種治療藥物的放射性核種治療機構百分比及放射性核種治療程序數量(以放射性核種治療藥物分類,2025 年)
  • 截至 2026 年調查日期,按設施類型分類的治療診斷學設施數量。
  • 治療診斷學:核醫檢測機構數量分佈及所進行的檢測項目類型(依機構類型分類,2025 年)
  • 使用特定放射性藥物的治療診斷學機構百分比以及按放射性藥物類型分類的治療診斷學手術數量(2025 年)
  • 截至 2026 年調查,您的部門是否在核醫 SPECT/CT 或 SPECT 掃描中使用過 PSMA 放射性藥物?
  • 心肌灌注測試:機構類型分佈、進行此測試的機構數量和患者數量(2025 年)
  • 2025年心肌灌注研究中使用的放射性試劑(包括單同位素和雙同位素)
  • 使用單一同位素和雙同位素進行心肌灌注研究的百分比(按機構類型分類,2025 年)
  • 使用特定藥物進行心肌灌注試驗的百分比(按醫療機構類型分類,2025 年)
  • 提供灌註注射的機構百分比(按注射類型分類,2026 年)
  • 2025 年按同位素和部位分類的灌註注射分佈。
  • 與 2025 年相比,2026 年使用Technetium-99m 製劑進行心肌灌注測試的患者研究比例會增加、保持不變還是減少?
  • 2025 例接受心肌灌注研究的病患分佈(依是否進行負荷試驗及依醫療機構類型分類)
  • 2025 年心肌灌注試驗患者研究分佈(依負荷模式、醫院及非醫院分類)
  • 心肌灌注研究中使用的藥物負載劑百分比(按加載劑、部位、2025 年分類)
  • 截至 2026 年調查時,2026 財政年度放射性藥物預算分配。
  • 2012-2026年放射性藥物、醫院及非醫院設施支出
  • 每家依醫療機構類型分類的醫療機構和每位病患放射性藥物平均支出(2026 年)
  • 與 2025 年相比,2026 年人均Technetium-99m 製劑劑量會增加、維持穩定還是減少?
  • 按放射性藥物來源和設施類型分類的核子醫學設施分佈(截至2026年的調查)
  • 2025年放射性藥物支出中供應商所佔佔有率(按設施類型分類)
  • 院內及院外核醫設施分佈(截至2026年)
  • 依醫院床位數分類的IMV認證核醫設施分佈(截至2026年的調查)
  • 都市區/郊區/鄉村地區位置(按地點類型分類)(截至2026年的調查)
  • 按設施類型分類的配備特定類型工作人員的核醫設施百分比(截至 2026 年的調查)
  • 核子醫學物理學家是否常駐各類醫療機構(截至2026年的調查)
  • 依解讀核醫影像的醫師人數和設施類型分類的設施分佈(截至 2026 年的調查)
  • 解讀核醫影像的醫師專業領域(依醫療機構類型分類)(截至 2026 年的調查)
  • 影像診斷機構中由醫師現場解讀的核醫檢查部位百分比(按部位類型分類)(截至 2026 年的調查)
  • 醫生用於解讀神經肌肉影像的數位工作站類型(按醫療機構類型分類)(截至 2026 年的調查)
  • 核子醫學科室財務狀況(依機構類型分類)(截至2026年的調查)
  • 核子醫學科室近期財務狀況(截至2026年的調查)
  • 一項關於核子醫學科最佳人員配備水準的調查(調查將於2026年進行)
  • 核子醫學科人員配置水準面臨的挑戰程度(依醫療機構類型分類,截至 2026 年的調查資料)
  • 新墨西哥州非緊急門診就診平均等待時間(依IMV調查年份分類,2011-2026年)
  • 非緊急神經系統疾病門診平均等待時間(醫院與非醫院的比較研究)(截至 2026 年的調查)
  • 依醫療機構類型分類的核子醫學科工作日預約安排時間(截至2026年的調查)
  • 按醫療機構類型分類的核子醫學科工作日開放時間(包括計劃內、計劃外和值班時間)(截至 2026 年的調查)
  • 新墨西哥州財政部財政穩健性展望-開放式回答摘要
  • 新墨西哥州分部人員配備挑戰-開放式回答摘要
  • 人工智慧對2025年新墨西哥州政府的影響—開放式回答
  • 預測人工智慧在2026年對新墨西哥州政府的影響—開放式回答
  • 新墨西哥州財政部財政穩健性展望-開放式回答
  • 新墨西哥州分部人員配置挑戰-開放式回答
  • 關於新墨西哥州設備和服務的提案—開放式回复
  • 調查方法
  • 關於IMV
簡介目錄
Product Code: 26-062

IMV’s 2026 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light of industry challenges. The report explores nuclear medicine market trends, including NM procedure volume, installed base features, use of OEM vs. third-party service providers, equipment purchase plans, radiopharmaceutical utilization/budgets, theranostics, and site operations characteristics. Survey results are projected to the identified universe of NM facilities.

What you’ll learn in this report

Nuclear medicine department priorities and future outlook

  • What are the key department priorities for NM?
  • What factors will impact the outlook for NM the most?
  • What are the preferred info sources for future NM purchases?
  • What are the top-ranked preferred uses of AI for NM?

Nuclear medicine procedures

  • How has NM volume changed in 2026?
  • What is the trend in NM procedure mix by procedure type?

NM scanner installed base and purchase plans

  • How many fixed NM units are installed by site type?
  • What is the trend in installed base market share by vendor?
  • What is the adoption rate for key NM capabilities?
  • What is the anticipated age of NM units upon replacement?
  • What is the mix of new vs. refurbished NM scanners?
  • What type of service providers are NM sites using?
  • What is the brand loyalty of current NM users?
  • What are the key buying criteria for future NM scanners?
  • What is the unit forecast for NM scanners for 2026 to 2028?

Theranostics

  • What are the most common theranostics procedures?
  • Which radiopharmaceuticals are utilized the most?

Site operations characteristics

  • How many technologists, nurses, administrators, imaging aides, and secretaries are employed in NM departments?
  • What % of sites & procedures use outside reading services

Market Research Methodology

This report utilizes the results from an IMV-hosted online survey conducted in February/April 2026 with 300 NM administrators, supervisors, and chief technologists from a random sample of hospitals and imaging centers in the US.

Table of Contents

  • Insight to Impact: How to Utilize this Report for Strategic Advantage
  • Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2026 Survey
  • Hospitals vs. Non-Hospitals: Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2026 Survey
  • Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, by Site Type, as of 2026 Survey
  • Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, by IMV Study Year, 2011 to 2026
  • Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, as of 2026 Survey
  • Hospitals vs. Non-Hospitals: Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, as of 2026 Survey
  • Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, by Site Type, as of 2026 Survey
  • Factors Affecting the Future Outlook for Nuclear Medicine at Your Facility Over the Next Few Years, by IMV Study Year, 2011 to 2026
  • Priority Ranking for Using Artificial Intelligence and Machine Learning Tools in NM Departments, as of 2026 Survey
  • #1/#2 Priority Ranking for Using Artificial Intelligence and Machine Learning Tools in NM Departments, by Site Type, as of 2026 Survey
  • Current Use and Consideration of Artificial Intelligence and Machine Learning Tools in NM Departments, as of 2026 Survey
  • Current Use and Consideration of Artificial Intelligence and Machine Learning Tools in Nuclear Medicine Departments, by Hospital vs. Non-Hospital, as of 2026 Survey
  • Current Use of Artificial Intelligence and Machine Learning Tools in Nuclear Medicine Departments, by Site Type, as of 2026 Survey
  • Outlook for NM Procedures, Reimbursement, Revenue, and Net Income, Compared to 2025
  • Outlook for NM Procedure Volume and Revenue, by IMV Study Year, 2011 to 2026
  • Strategic Actions Being Considered Over the Next Few Years, as of 2026 Survey
  • Strategic Actions Being Considered Over the Next Few Years, by Hospital vs. Non-Hospitals, as of 2026 Survey
  • Strategic Actions Being Considered Over the Next Few Years, by Site Type, as of 2026 Survey
  • AI Impact on NM Department in 2025 – Summary of Open-Ended Responses
  • Anticipated AI Impact on NM Department in 2026 – Summary of Open-Ended Responses
  • NM Equipment & Services Suggestions – Summary of Open-Ended Responses
  • Total Nuclear Medicine Patient Studies, Hospital and Non-Hospital Sites, 2002 to 2025
  • Distribution of Nuclear Medicine Sites and Patient Studies, by Site Type, 2026
  • Trend in Average Nuclear Medicine Patient Studies per Site, by Site Type, 2017 to 2025
  • Distribution of 2025 Nuclear Medicine Patient Studies Performed on SPECT-CT, SPECT-only and Planar-only Cameras, by Site Type
  • Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, as of 2026 Survey
  • Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, by Site Type, as of 2026 Survey
  • Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the Next Three Years, by Site Type, as of 2026 Survey (continued)
  • Nuclear Medicine 2025 Patient Study Mix, by Procedure Category, All Sites
  • Distribution of Nuclear Medicine Patient Studies, by Procedure Type, 2018 to 2025
  • Distribution of Nuclear Medicine Patient Studies, by Procedure Type, Hospitals and Non-Hospitals, 2010 to 2025
  • Whether the Total Number of NM Patient Studies in 2026 is Anticipated to Increase, Stay the Same, or Decrease, Compared to 2025, by Site Type
  • Whether Proportion of NM Patient Studies Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025, by Procedure Type
  • Percent of Sites Performing Nuclear Medicine Studies and Average Annual Nuclear Medicine Patient Studies per Site Performing, by Procedure Type, Hospitals and Non-Hospitals, as of 2026 Survey
  • Percent of Sites Performing Nuclear Medicine Studies, by Procedure Type, by IMV Study Year, 2018 to 2025
  • Mix of Inpatient, Outpatient, vs. Emergency Nuclear Medicine Patient Studies, by Site Type, 2025
  • Percentage of SPECT/CT Sites Performing Patient Studies with Diagnostic CT Scans, as of 2026 Survey
  • Percentage of SPECT/CT Sites Performing Diagnostic CT-only Scans with No Associated SPECT Scans, as of 2026 Survey
  • Distribution of Nuclear Medicine Sites and Cameras, Hospital & Non-Hospital Sites, as of 2026 Survey
  • Trend in Installed Base of Nuclear Medicine Cameras, Hospital & Non-Hospital Sites, by IMV Study Year, 2011 to 2026
  • Distribution of Sites, by Number of Nuclear Medicine Cameras Installed, by Site Type, as of 2026 Survey
  • Nuclear Medicine Camera Installed Base Share, by Manufacturer, as of 2026 Survey
  • Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation, as of 2026 Survey
  • Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation, by Site Type, as of 2026 Survey
  • Distribution of Nuclear Medicine Cameras Installed Base, by Camera Type, by Site Type, as of 2026 Survey
  • Trend in Nuclear Medicine Camera Installed Base Mix, by Camera Type, by IMV Study Year, 2011 to 2026
  • Nuclear Medicine Camera Installed Base Share, by Camera Type, as of 2026 Survey
  • Nuclear Medicine Camera Installed Base Share, for Units Installed in the Last 6 Years, as of 2026 Survey
  • Distribution of Installed SPECT/CT Cameras, by Number of CT Slices, as of 2026 Survey
  • Whether the SPECT or SPECT/CT is a General Purpose or Dedicated Cardiac Camera, by Site Type, as of 2026 Survey
  • Whether the SPECT or SPECT/CT has a Solid State Detector, by Site Type, as of 2026 Survey
  • Whether the SPECT or SPECT/CT was Purchased New or Refurbished, by Site Type, as of 2026 Survey
  • Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras, by Site Type, as of 2026 Survey
  • Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras, by Year Installed, as of 2026 Survey
  • Type of Service Contractual Arrangement for Nuclear Medicine Cameras, by Site Type, as of 2026 Survey
  • Primary Source of NM Service Support, by Whether the SPECT or SPECT/CT was Originally Purchased New or Refurbished, as of 2026 Survey
  • Purchase Plans for Nuclear Medicine Cameras Over the Next Three Years, as of 2026 Survey
  • Percent of Sites Planning to Purchase Nuclear Medicine Cameras Over the Next Three Years, by IMV Study Year, 2011 to 2026
  • Type of Nuclear Medicine Camera Planned for Purchase, as of 2026 Survey
  • Type of Nuclear Medicine Cameras Planned for Purchase, by IMV Study Year, 2011 to 2026
  • Whether Planned Nuclear Medicine Cameras Will be a General Purpose or Dedicated Cardiac Camera, as of 2026 Survey
  • Planned SPECT/CT Cameras, by Number of CT Slices, as of 2026 Survey
  • Plans for New vs. Refurbished Nuclear Medicine Cameras, by Site Type, as of 2026 Survey
  • Plans for Replacement and Additional Nuclear Medicine Cameras, as of 2026 Survey
  • Percent Distribution of Sites Mentioning Manufacturers Considered for Next Nuclear Medicine Camera Purchase, as of 2026 Survey
  • Brand Loyalty: Nuclear Medicine Camera Manufacturers Being Considered, by Current Camera Installed Base, as of 2026 Survey
  • Annual 2026-2028 Budget Status for All Cameras Planned for Purchase, as of 2026 Survey
  • Distribution of 2026 Nuclear Medicine Equipment Budgets, as of 2026 Survey
  • Distribution of 2025-2028 NM Equipment Budgets, as of 2026 Survey
  • Distribution of 2025-2028 NM Equipment Budgets, by Site Type, as of 2026 Survey
  • Average Nuclear Medicine Equipment Budget per Site, by Site Type, by IMV Study Year, 2018 to 2026
  • Percentage of Sites Planning to Complete Capital Projects from 2026 to 2028, as of 2026 Survey
  • Nuclear Medicine Camera Replacement Cycle, Based on 2026 Survey Responses
  • Facilities Performing Radionuclide Therapy, by Site Type, as of 2026 Survey
  • Radionuclide Therapy: Distribution of Nuclear Medicine Sites Performing and Procedures Performed, by Site Type, 2025
  • Percentage of Radionuclide Therapy Sites Using Radionuclide Therapy Agents and Radionuclide Therapy Procedure Volume, by Radionuclide Agents, 2025
  • Facilities Performing Theranostics, by Site Type, as of 2026 Survey
  • Theranostics: Distribution of Nuclear Medicine Sites Performing and Procedures Performed, by Site Type, 2025
  • Percentage of Theranostics Sites Using Specific Radiopharmaceutical Agents and Theranostics Procedure Volume, by Radiopharmaceutical Agents, 2025
  • Were PSMA Radiopharmaceuticals Used for Any NM SPECT/CT or SPECT Scans in Your Department, as of 2026 Survey
  • Myocardial Perfusion Studies: Distribution of NM Sites Performing and Patient Studies, by Site Type, 2025
  • Radioactive Agent Used for Myocardial Perfusion Studies, Including Single & Dual Isotopes, 2025
  • Percent of Myocardial Perfusion Studies Using Single vs. Dual Isotopes, by Site Type, 2025
  • Percentage of Myocardial Perfusion Studies, Using Specified Agents, by Site Type, 2025
  • Percentage of Sites Providing Perfusion Injections, by Injection Type, 2026
  • Distribution of Perfusion Injections, by Isotope, by Site Type, 2025
  • Whether the Proportion of Myocardial Perfusion Patient Studies Using Technetium-99m Agents Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025
  • Distribution of 2025 Myocardial Perfusion Patient Studies, by Whether Imaged with Stress or Not, by Site Type
  • Distribution of 2025 Myocardial Perfusion Patient Studies, by Stress Mode, Hospitals and Non-Hospitals
  • Percent of Myocardial Perfusion Studies Using Pharmaceutical Stress Agents, by Stress Agent, by Site Type, 2025
  • Distribution of 2026 Radiopharmaceutical Budgets, as of 2026 Survey
  • Radiopharmaceutical Expenditures, Hospital and Non-Hospital Sites, 2012 to 2026
  • Average Radiopharmaceutical Expenditures per Site and per Patient Study, by Site Type, 2026
  • Whether the Price per Patient Dose for Technetium-99m Agents Will Increase, Stay the Same, or Decrease in 2026, Compared to 2025
  • Distribution of Nuclear Medicine Sites, by Source of Radiopharmaceuticals, by Site Type, as of 2026 Survey
  • Supplier Share of 2025 Radiopharmaceutical Expenditures, by Site Type
  • Distribution of Hospital vs. Non-Hospital Nuclear Medicine Sites, as of 2026 Survey
  • Distribution of IMV-Identified Hospital-Based Nuclear Medicine Sites, by Hospital Bed Size, as of 2026 Survey
  • Urban/Suburban/Rural Locations, by Site Type, as of 2026 Survey
  • Percent of Nuclear Medicine Sites with Specified Staff Types, by Site Type, as of 2026 Survey
  • Whether Facility has a Nuclear Medicine Physicist on Staff, by Site Type, as of 2026 Survey
  • Distribution of Sites by Number of Physicians that Read Nuclear Medicine Studies, by Site Type, as of 2026 Survey
  • Specialties of Physicians Who Read Nuclear Medicine Studies, by Site Type, as of 2026 Survey
  • Percentage of NM Sites Read On-Site by Physicians at the Imaging Facility, by Site Type, as of 2026 Survey
  • Types of Digital Workstations Used by Physicians for Reading and Interpreting NM Exams, by Site Type, as of 2026 Survey
  • Financial Health of Nuclear Medicine Department in 2026, by Site Type
  • Financial Health of Nuclear Medicine Department in Recent Years, as of 2026 Survey
  • Whether Nuclear Medicine Department is at Optimal Staffing Levels, as of 2026 Survey
  • Level of Staffing Challenges in Nuclear Medicine Department, by Site Type, as of 2026 Survey
  • Average Waiting Time for a Non-Emergency NM Outpatient Visit, by IMV Study Year, 2011 to 2026
  • Average Waiting Time for a Non-Emergency NM Outpatient Visit, Hospitals vs. Non-Hospitals, as of 2026 Survey
  • Hours per Weekday Nuclear Medicine Department Open for Scheduled Procedures, by Site Type, as of 2026 Survey
  • Hours per Weekday Nuclear Medicine Department Open Including Scheduled, Unscheduled, and On-Call Procedures, by Site Type, as of 2026 Survey
  • NM Department Financial Health Outlook – Summary of Open-Ended Responses
  • NM Department Staffing Challenges – Summary of Open-Ended Responses
  • AI Impact on NM Department in 2025 – Open-Ended Responses
  • AI Impact on NM Department in 2025 – Open-Ended Responses (continued)
  • AI Impact on NM Department in 2025 – Open-Ended Responses (continued)
  • AI Impact on NM Department in 2025 – Open-Ended Responses (continued)
  • Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses
  • Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued)
  • Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued)
  • Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued)
  • Anticipated AI Impact on NM Department in 2026 – Open-Ended Responses (continued)
  • NM Department Financial Health Outlook – Open-Ended Responses
  • NM Department Financial Health Outlook – Open-Ended Responses (continued)
  • NM Department Financial Health Outlook – Open-Ended Responses (continued)
  • NM Department Financial Health Outlook – Open-Ended Responses (continued)
  • NM Department Financial Health Outlook – Open-Ended Responses (continued)
  • NM Department Staffing Challenges – Open-Ended Responses
  • NM Department Staffing Challenges – Open-Ended Responses (continued)
  • NM Department Staffing Challenges – Open-Ended Responses (continued)
  • NM Department Staffing Challenges – Open-Ended Responses (continued)
  • NM Department Staffing Challenges – Open-Ended Responses (continued)
  • NM Department Staffing Challenges – Open-Ended Responses (continued)
  • NM Equipment & Services Suggestions – Open-Ended Responses
  • NM Equipment & Services Suggestions – Open-Ended Responses (continued)
  • NM Equipment & Services Suggestions – Open-Ended Responses (continued)
  • NM Equipment & Services Suggestions – Open-Ended Responses (continued)
  • Methodology
  • About IMV